Financial Advocates Investment Management Raises Stock Holdings in Welltower Inc. (NYSE:WELL)

Financial Advocates Investment Management boosted its position in Welltower Inc. (NYSE:WELLFree Report) by 10.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,032 shares of the real estate investment trust’s stock after purchasing an additional 276 shares during the quarter. Financial Advocates Investment Management’s holdings in Welltower were worth $382,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Laurel Wealth Advisors LLC acquired a new position in shares of Welltower in the fourth quarter valued at approximately $25,000. Fortitude Family Office LLC grew its stake in Welltower by 37.0% in the 3rd quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 78 shares during the period. Versant Capital Management Inc raised its holdings in Welltower by 165.5% in the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock valued at $38,000 after acquiring an additional 187 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in shares of Welltower during the 3rd quarter worth $50,000. Finally, FSA Wealth Management LLC acquired a new stake in shares of Welltower during the third quarter worth $59,000. 94.80% of the stock is currently owned by hedge funds and other institutional investors.

Welltower Price Performance

Shares of NYSE:WELL opened at $142.66 on Monday. The company has a market cap of $88.83 billion, a PE ratio of 93.86, a P/E/G ratio of 2.83 and a beta of 1.23. Welltower Inc. has a fifty-two week low of $85.40 and a fifty-two week high of $143.39. The firm has a 50-day simple moving average of $130.34 and a 200 day simple moving average of $127.67. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Raymond James upped their target price on Welltower from $145.00 to $155.00 and gave the company a “strong-buy” rating in a research note on Monday, December 16th. StockNews.com upgraded shares of Welltower from a “sell” rating to a “hold” rating in a report on Wednesday, October 30th. Bank of America boosted their target price on shares of Welltower from $190.00 to $221.00 and gave the company a “buy” rating in a report on Friday, January 24th. Mizuho increased their price target on shares of Welltower from $136.00 to $141.00 and gave the stock an “outperform” rating in a research note on Thursday, December 5th. Finally, Scotiabank upped their price objective on Welltower from $142.00 to $144.00 and gave the stock a “sector outperform” rating in a report on Monday, January 27th. Five research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $134.96.

View Our Latest Stock Report on WELL

Welltower Profile

(Free Report)

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.

Featured Articles

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.